Lithium in ALS: From the bench to the bedside

Amyotrophic Lateral Sclerosis

Volumn 9, Issue 2, 2008, Pages 123-124

  Fornai, Francesco ^a,b   Siciliano, Gabriele ^a   Manca, Maria Laura ^a   Murri, Luigi ^a   Paparelli, Antonio ^a   Ruggieri, Stefano ^b  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; LITHIUM; PLACEBO; RAPAMYCIN; RILUZOLE;

ABSENCE OF SIDE EFFECTS; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; CELL PROLIFERATION; CLINICAL TRIAL; DRUG EFFICACY; GLIA CELL; HUMAN; MOTONEURON; MUTATIONAL ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; NOTE; PILOT STUDY; PRIORITY JOURNAL; SURVIVAL TIME;

ADJUVANTS, IMMUNOLOGIC; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; LITHIUM CHLORIDE; PATIENT SELECTION; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 42549108749     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802028197     Document Type: Note

References (1)

1. Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M. and Manca, M. L. (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A, 105, pp. 2052-2057.